News from the Web

Filter

Current filters:

Biotechnology

1601 to 1610 of 11033 results

Perjeta may be first early-stage breast cancer pharmaceutical option

11-09-2013

WASHINGTONPerjeta may become the first pharmaceutical treatment approved to treat early-stage breast…

Sagent Pharmaceuticals Announces Upsizing and Pricing of Offering of ...

11-09-2013

SCHAUMBURG, Ill., Sept. 10, 2013 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader…

FDA Offers Guidance for Advair Knockoffs

11-09-2013

The new clarity could allow for generics to potentially hit the market by 2016 or 2017, some analysts…

How US biotechnology bull run will affect Australia

10-09-2013

The lower Aussie dollar, a well regarded local clinical trials industry, and a frothy US biotechnology…

GSK shares hit as Advair generic threat grows in US

10-09-2013

Chances of cheaper versions of the $8 billion-a-year seller being launched in the world's biggest…

TWi Biotechnology Receives Patent Allowance for Its Lead Drug Candidate AC ...

10-09-2013

TAIPEI, Sept. 10, 2013 /PRNewswire/ -- TWi Biotechnology, Inc., today announced that it has received…

Sunshine Act 2013 Updates: A Checklist for Pharmaceutical Companies to Meet ...

10-09-2013

From August 1, 2013, the Sunshine Act is put in effect. The pharmaceutical companies and medical device…

Shares in Sihuan Pharmaceutical Tumble After Block Sale

10-09-2013

Shares of Chinese drug maker Sihuan Pharmaceutical Holdings Group Ltd. tumbled 10.4% in Hong Kong on…

Health Canada must make birth control pills safer, especially generics: Editorial

10-09-2013

When taking a pill it's reasonable to expect that what you're swallowing is precisely what your…

1601 to 1610 of 11033 results

Back to top